AUDIENCE: Psychiatry, Patients
ISSUE: FDA notified healthcare professionals and patients that serious allergic reactions have been reported with the use of Saphris (asenapine maleate). The Contraindications, Warnings and Precautions, Adverse Reactions, and Patient Counseling Information sections have been revised to include information about type I hypersensitivity reactions which may include anaphylaxis, angioedema, low blood pressure, rapid heart rate, swollen tongue, difficulty breathing, wheezing, or rash. In several cases, these reactions occurred after the first dose.
BACKGROUND: Saphris (asenapine maleate) is used to treat symptoms of schizophrenia and bipolar disorder.
RECOMMENDATION: Healthcare professionals should be aware of the risk of hypersensitivity reactions with Saphris and counsel patients who are receiving the drug about how to recognize the signs and symptoms of a serious allergic reaction. Saphris should not be used in patients with a known hypersensitivity to the drug.
Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program ...more
LINKING POLICY AND DISCLAIMER
Healthesystems may link to other Web sites created and maintained by other public and/or private organizations. Healthesystems provides links to those Web sites as a service to our users. The presence of a link is not a Healthesystems endorsement of the Web site nor is it a guarantee that every similar link will be provided, e.g., not all FDA recalls will be provided as a link on this site.
When users follow a link to an outside Web site, they are leaving Healthesystems and are subject to the privacy and security policies of the owners/sponsors of the outside Web site(s). Healthesystems is not responsible for information collection practices on non-Healthesystems Web sites.
Changes to this Statement
Healthesystems will occasionally update this Privacy Statement to reflect company and customer feedback. Healthesystems encourages you to periodically review this Statement to be informed of how Healthesystems is protecting your information.
Contact Information
Healthesystems welcomes your comments regarding this Privacy Statement. If you believe that Healthesystems has not adhered to this Statement, please contact Healthesystems at communications@healthesystems.com. We will use commercially reasonable efforts to promptly determine and remedy the problem.